(2026). Gene-specific response to muscle specific kinase agonist antibody in the treatment of congenital myasthenic syndromes. Brain Communications.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Gene-specific Response to Muscle Specific Kinase Agonist Antibody in the Treatment of Congenital Myasthenic Syndromes."
Brain Communications 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Gene-specific Response to Muscle Specific Kinase Agonist Antibody in the Treatment of Congenital Myasthenic Syndromes."
Brain Communications, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.